Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-14-017291
Filing Date
2014-04-23
Accepted
2014-04-23 10:02:27
Documents
1
Effectiveness Date
2014-04-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10180
  Complete submission text file 0001140361-14-017291.txt   11351
Mailing Address 142 WEST 57TH STREET SUITE 4A NEW YORK NY 10019
Business Address 142 WEST 57TH STREET SUITE 4A NEW YORK NY 10019 646-367-5905
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-216074 | Film No.: 14777716